Practical Analytical and Clinical Validation Strategies for Cell-Free Tumor DNA Assays

This webinar is a recorded presentation of a live broadcast and includes a pre-test, the presentation, handout, and a post-test. Continuing education credit is available for the webinar.

This interactive webinar is part 2 of the 8-part Utility of Cell-Free DNA in the Clinic Series.


There is increasing adoption of circulating tumor DNA (ctDNA) assays in molecular oncology. Ensuring that technical and compliance requirements for clinical lab testing are met can be particularly challenging for ctDNA assays. This presentation will include discussion of analytical validation strategies for ctDNA assays to establish that assays perform as intended.

Learning Objectives:

1.       Define cell-free DNA (cfDNA), and recognize its dynamics in health and disease.
2.       Understand challenges unique to cfDNA assay validation.
3.       Identify solutions for analytically validating cfDNA assays.
4.       Discuss opportunities and limitations for assessing circulating tumor DNA (ctDNA) in oncology.

Christina Lockwood, MD
Meera Hameed, MD

Recording Date: July 27, 2021
Duration: 1 hr
Level of Instruction: Basic
CME/CMLE credit: 1.00 hour

Last Day to Claim Credit: December 31, 2023

Continuing Education Credit Information

Physicians (ACCME)           

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Association for Molecular Pathology.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live to enduring activity for a maximum of 8.00 AMA PRA Category 1 CreditsTM (1.00 CE for each webinar). Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Medical Laboratory Education (CMLE)

This activity has been planned and implemented in accordance with the Amedco and joint provider-ship of the ASC and the Association for Molecular Pathology (AMP). Course number 7013.

Supported by an educational grant from AstraZeneca   

Note: Join the AMP Family for discounted access to the most current educational resources!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation